A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas

NCT05566743 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Pancreas

Interventions

DRUG: Capecitabine
OTHER: follow up

Sponsor

Menoufia University